GILEAD SCIENCES, INC. (GILD) Total liabilities 2016–2025
GILEAD SCIENCES, INC. (GILD) total liabilities at each fiscal year-end, per SEC filings.
$36.3BFY2025 · since FY2016: $38.1B → $36.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $36.3B | -8.4% |
| FY2024 | $39.7B | +0.9% |
| FY2023 | $39.3B | -6.3% |
| FY2022 | $41.9B | -10.6% |
| FY2021 | $46.9B | -6.6% |
| FY2020 | $50.2B | +28.4% |
| FY2019 | $39.1B | -7.5% |
| FY2018 | $42.3B | -15.2% |
| FY2017 | $49.8B | +30.9% |
| FY2016 | $38.1B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GILD financial trends
GILD RevenueGILD Net incomeGILD Net marginGILD Gross profitGILD Gross marginGILD Operating incomeGILD Operating marginGILD Operating cash flowGILD Free cash flowGILD Capital expendituresGILD Return on equityGILD Stock buybacksGILD Dividends paidGILD Total assetsGILD Shareholders’ equityGILD overview →